Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Radiodermatitis × Sodium Chloride × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 30 Neoplasms 10 Pain, Postoperative 9 Lung Neoplasms 9 Colorectal Neoplasms 9 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 7 Stomach Neoplasms 6 Prostatic Neoplasms 5 Melanoma 5 Ovarian Neoplasms 4 Leiomyoma 4 Hemorrhage 4 Glioblastoma 4 Colonic Neoplasms 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Fatigue 3 Delirium 3 Chronic Pain 3 Agnosia 3 Uterine Cervical Neoplasms 2

Interventions

Standard of Care 4 Low-Level Light Therapy 4 Petrolatum 3 Norepinephrine 3 sapropterin 2 Curcumin 2 triethanolamine 1 eucerin 1 epigallocatechin gallate 1 dimethicone 1 cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1 calcipotriene 1 Zinc Oxide 1 Triamcinolone Acetonide 1 Thioctic Acid 1 Sodium Hypochlorite 1 Sodium Chloride 1 Silver Sulfadiazine 1 Radiotherapy, Conformal 1 Radiotherapy 1 Melatonin 1 Hydrogel, Polyethylene Glycol Dimethacrylate 1 Hydrocortisone 1 Gels 1 Dimethyl Sulfoxide 1 Catechin 1 Biafine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07149506 2025-09-08

OCTOPUS-RD

Universidad de Guanajuato

Phase 3 Enrolling by invitation

Fibrosis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡